ePOSTER
GENERAL SEARCH
GENERAL SEARCH
Session Title
Title
Poster Number
Author
Presenter
Filter By
Session Name
Select All
Deselect All
AS01 - Allergy and Airway
12
AS02 - Biotechnology
3
AS03 - Cardiothoracic Surgery
13
AS04 - Cardiovascular Disease
12
AS05 - Chest Infections
40
AS06 - Critical Care
26
AS08 - Diffuse Lung Disease
23
AS10 - Disorders of the Mediastinum
7
AS11 - Disorders of the Pleura
11
AS12 - Education, Research, and Quality Improvement
6
AS13 - Genetic and Developmental Disorders
3
AS14 - Imaging
8
AS15 - Procedures
19
AS16 - Lung Cancer
21
AS17 - Lung Pathology
4
AS18 - Obstructive Lung Diseases
22
AS19 - Occupational and Environmental Lung Diseases
5
AS20 - Palliative Care and End of Life Issues
2
AS21 - Pediatrics
7
AS22 - Pharmacotherapeutics
8
AS24 - Pulmonary Manifestations of Systemic Disease
16
AS25 - Pulmonary Physiology
4
AS26 - Pulmonary Rehabilitation
6
AS27 - Pulmonary Vascular Disease
13
AS28 - Respiratory Care
8
AS29 - Signs and Symptoms of Chest Diseases
3
AS30 - Sleep Disorders
5
AS31 - Tobacco Cessation and Prevention
8
AS32 - Transplantation
3
Presentation Type
Select All
Deselect All
Abstract Submission
275
Late Breaking Abstract
21
Late Breaking Case Report
22
Cancel
Clear
Search
Not Signed in
Bookmarks
Sign in
HOME
ePoster Home
ePoster Authors
AN UNUSUAL PRESENTATION OF CHRONIC EOSINOPHILIC PNEUMONIA
AS01 - Allergy and Airway
Abstract Publication
CEP.mp3
AN UNUSUAL PRESENTATION OF CHRONIC EOSINOPHILIC PNEUMONIA
Session Name
AS01 - Allergy and Airway
Presentation Type
Abstract Submission
ePoster Audio MP3
Next Poster
Next ePosters
THE ASTHMA – OBSTRUCTIVE SLEEP APNOEA CO-EXISTENCE DECREASES HIGH DENSITY LIPOPROTEIN CHOLESTEROL, BUT HAS NO SIGNIFICANT EFFECT ON TRIGLYCERIDES AND LOW DENSITY LIPOPROTEIN CHOLESTEROL
BASELINE CHARACTERISTICS FROM A PHASE 3, RANDOMIZED CONTROLLED TRIAL (COUGH-2) OF GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN REFRACTORY OR UNEXPLAINED CHRONIC COUGH
ANGIOTENSIN- (1-7) INDUCES RESOLUTION OF INFLAMMATION AND PROTECTS LUNG TISSUE FROM NEW INFLAMMATORY STIMULI.
HAVING TO TREAT ASTHMA WITHOUT INHALED CORTICOSTEROIDS (OR A CUSHING SYNDROME CASE DUE TO INHALED CORTICOSTEROIDS)
REAL-LIFE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA WITH BENRALIZUMAB
EPINEPHRINE CAUSES SEVERE LACTIC ACIDOSIS IN A PATIENT WITH SHELLFISH INDUCED ANAPHYLAXIS
LUNG MASS AND HEMOPTYSIS IN AN ELDERLY MAN WITH CONTROLLED ASTHMA
RESET OF PERINUCLEAR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (P-ANCA) IN PATIENT WITH SEVERE ASTHMA AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) DURING BENRALIZUMAB TREATMENT
ABPA IN SEVERE ASTHMA: EFFECT OF TREATMENT IN PATIENTS WITH ACUTE AND WITH EXACERBATED DISEASE
UNUSUAL CAUSE OF RECURRENT BRONCHOSPASM – PLASTIC BRONCHITIS IN AN ADULT FEMALE.